Literature DB >> 16321689

Determinants of rapid progression of aortic root dilatation and complications in Marfan syndrome.

Aleksandar M Lazarevic1, Satoshi Nakatani, Yutaka Okita, Jelena Marinkovic, Yutaka Takeda, Keiji Hirooka, Hiroshi Matsuo, Soichiro Kitamura, Masakazu Yamagishi, Kunio Miyatake.   

Abstract

BACKGROUND: Progressive aortic dilatation has prognostic significance in the Marfan syndrome.
METHODS: To identify which patients were at high risk of rapid progression, we echocardiographically studied 43 patients (age 22 +/- 14 years) with the mean follow-up period of 5.2 +/- 3.2 years. Aortic diameters, left ventricular (LV) size, fractional shortening, and the severity of aortic and mitral regurgitation were assessed. Transmitral peak early and atrial flow velocities, their ratio and the deceleration time of peak early velocity were also obtained.
RESULTS: Mean annual increases of aortic diameters were 0.4 +/- 0.3 mm at the annulus, 1.5 +/- 1.3 mm at the sinuses of Valsalva, 0.7 +/- 0.6 mm at the supraaortic ridge and 0.4 +/- 0.4 mm at the proximal ascending aorta. Patients were divided into 2 groups according to the aortic growth rate at the sinuses of Valsalva level: rapid (R, >3% per year, 15 patients) or slow (S, < or =3% per year, 28 patients) progression groups. Measured variables did not show significant differences between the 2 groups except older age, higher blood pressure and more severe aortic regurgitation in group R. Multiple regression analysis identified prolonged deceleration time as the most important variable predicting aortic complications. Aortic dissection occurred more frequently in group R (7 patients, 47%) than in group S (0%, P < 0.001).
CONCLUSIONS: Marfan patients at older age, with higher blood pressure, and with significant aortic regurgitation were at high risk of progression of aortic dilatation, with the most remarkable increase at the sinuses of Valsalva. Prolonged deceleration time may relate to an increased risk for aortic complications.

Entities:  

Mesh:

Year:  2006        PMID: 16321689     DOI: 10.1016/j.ijcard.2005.01.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Aortic Involvement in Pediatric Marfan syndrome: A Review.

Authors:  Omonigho Ekhomu; Zahra J Naheed
Journal:  Pediatr Cardiol       Date:  2015-02-11       Impact factor: 1.655

2.  Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome.

Authors:  Arvind Hoskoppal; Shaji Menon; Felicia Trachtenberg; Kristin M Burns; Julie De Backer; Bruce D Gelb; Marie Gleason; Jeanne James; Wyman W Lai; Aimee Liou; Lynn Mahony; Aaron K Olson; Reed E Pyeritz; Angela M Sharkey; Mario Stylianou; Stephanie Burns Wechsler; Luciana Young; Jami C Levine; Elif Seda Selamet Tierney; Ronald V Lacro; Timothy J Bradley
Journal:  Pediatr Cardiol       Date:  2018-06-11       Impact factor: 1.655

3.  The distal aorta in the Marfan syndrome.

Authors:  B J M Mulder
Journal:  Neth Heart J       Date:  2008-11       Impact factor: 2.380

Review 4.  Into the Tissues: Extracellular Matrix and Its Artificial Substitutes: Cell Signalling Mechanisms.

Authors:  Aleksandra Bandzerewicz; Agnieszka Gadomska-Gajadhur
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

5.  Poor management of hypertension is an important precipitating factor for the development of acute aortic dissection.

Authors:  Ning Dong; Hulin Piao; Bo Li; Jian Xu; Shibo Wei; Kexiang Liu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-20       Impact factor: 3.738

6.  Predictors for aneurismal formation.

Authors:  B J M Mulder; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-04-16       Impact factor: 2.357

7.  Magnetic resonance angiography derived predictors of progressive dilatation and surgery of the aortic root in Marfan syndrome.

Authors:  Julius Matthias Weinrich; Alexander Lenz; Gerhard Schön; Cyrus Behzadi; Isabel Molwitz; Frank Oliver Henes; Bjoern Philip Schoennagel; Gerhard Adam; Yskert von Kodolitsch; Peter Bannas
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.